Evidence map›Paper›PMID 40860634›Full record

ArticleACS engineering Au2025

Process and Formulation Parameters Governing Polymeric Microparticle Formation via Sequential NanoPrecipitation (SNaP).

Parker K Lewis, Nouha El Amri, Erica E Burnham, Natalia Arrus, Nathalie M Pinkerton

Abstract read
In one paragraph

Article in ACS engineering Au, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Engineering Nanoscale Drug Delivery Systems for Pain.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Parker K LewisDepartment of Chemical and Biomolecular Engineering, Tandon School of Engineering, New York University, Brooklyn 11201, United States.
Nouha El AmriDepartment of Chemical and Biomolecular Engineering, Tandon School of Engineering, New York University, Brooklyn 11201, United States.
Erica E BurnhamDepartment of Chemical and Biomolecular Engineering, Tandon School of Engineering, New York University, Brooklyn 11201, United States.
Natalia ArrusDepartment of Mechanical and Aerospace Engineering, Tandon School of Engineering, New York University, Brooklyn 11201, United States.
Nathalie M PinkertonDepartment of Chemical and Biomolecular Engineering, Tandon School of Engineering, New York University, Brooklyn 11201, United States.ORCID https://orcid.org/0000-0001-9325-9764

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polymeric microparticles (MPs) are valuable drug delivery vehicles for extended-release applications, but current manufacturing techniques present significant challenges in balancing size control with scalability. Industrial synthesis processes provide high throughput but limited precision, while laboratory-scale technologies offer precise control but poor scalability. This study explores Sequential NanoPrecipitation (SNaP), a two-step controlled precipitation process for polymeric microparticle production, to bridge the gap between laboratory precision and industrial scalability. We systematically investigated critical process parameters governing MP formation, focusing on poly-(lactic acid) (PLA) MPs stabilized with poly-(vinyl alcohol) (PVA). By comparing vortex and impinging jet mixing geometries, we demonstrated that vortex mixing provides superior performance for core assembly, particularly at higher polymer concentrations. We established the influence of delay time (

Indexed as

continuous flow manufacturingdrug deliverymicroparticlepolymer microparticlesequential nanoprecipitation

Identifiers

PMID40860634
PMCPMC12371724

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.